Tag: GLP-1 drugs

Market News

Eli Lilly Price Target Raised After Another Strong Earnings Beat

Eli Lilly just crushed expectations again with its weight-loss and diabetes drugs driving explosive growth. We raised our price target,...

05/08/2026

3 views

Read More

Market News

Logistics Giants Race to Meet Healthcare Boom Driven by GLP-1 Surge

As weight-loss injections reshape patient lives, behind the scenes logistics companies are scrambling to keep medicines effective during shipping. What...

25/07/2026

6 views

Read More

Market News

Jim Cramer Stands by Eli Lilly Despite Rival GLP-1 Lawsuit

Jim Cramer just doubled down on Eli Lilly even as a major rival launches a lawsuit over their popular GLP-1...

21/07/2026

5 views

Read More

Market News

Novo Nordisk Sues Eli Lilly Over GLP-1 Deceptive Ads

The GLP-1 giants are at war. Novo Nordisk just sued Eli Lilly for deceptive advertising that supposedly confuses patients comparing...

21/07/2026

3 views

Read More

Market News

America’s Protein Boom Strains Dairy Industry Supply

America can't get enough protein these days, with whey inventories cut in half and prices climbingGenerating the protein industry blog...

28/06/2026

5 views

Read More

Global Companies

UPS Invests $48 Million in Cold Chain Facilities Amid Healthcare Logistics Boom

UPS is pouring $48 million into temperature-controlled facilities as demand for specialized medicines like GLP-1s explodes. But what does this...

23/06/2026

4 views

Read More

Market News

Why Salty Snack Demand Remains Stale Amid Economic Pressures

Salty snacks have long been a go-to comfort food, but recent data shows demand hitting a wall. Between new medications,...

16/06/2026

2 views

Read More

Market News

Novo Nordisk and Eli Lilly Compete in Obesity Pill Market Ahead of Medicare Coverage

Have you ever wondered what happens when two pharmaceutical powerhouses go head-to-head in one of the biggest health markets of...

08/06/2026

5 views

Read More

Market News

Eli Lilly Deploys GLP-1 Windfall Into Aggressive M&A Strategy

Eli Lilly has already committed over $10 billion to acquisitions this year alone, fueled by its blockbuster weight-loss drugs. But...

03/06/2026

3 views

Read More

Global Companies

Novo Nordisk Faces Ozempic Generics Challenge in Canada

The first generic versions of Ozempic have just been approved in Canada, marking a potential turning point for Novo Nordisk's...

11/05/2026

4 views

Read More